Staging of Untreated Patients With Very High-risk and High-risk Prostate Carcinoma Utilizing Hybrid C11-choline PET/MR and Pelvic Multiparametric MRI for Personalized Precise Treatment: a Pilot Study
Phase of Trial: Phase III
Latest Information Update: 23 Aug 2018
At a glance
- Drugs Gadobutrol (Primary)
- Indications Adenocarcinoma; Prostate cancer
- Focus Diagnostic use
- 17 Aug 2018 Planned End Date changed from 1 Sep 2018 to 27 Aug 2019.
- 17 Aug 2018 Planned primary completion date changed from 1 Jul 2018 to 27 Aug 2019.
- 20 Mar 2018 Status changed from not yet recruiting to recruiting.